gadolinium dtpa has been researched along with sirolimus in 2 studies
Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (sirolimus) | Trials (sirolimus) | Recent Studies (post-2010) (sirolimus) |
---|---|---|---|---|---|
12,654 | 664 | 4,051 | 20,711 | 2,368 | 11,516 |
Protein | Taxonomy | gadolinium dtpa (IC50) | sirolimus (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 10 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.25 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 2 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 2 | |
Peptidyl-prolyl cis-trans isomerase FKBP1A | Mus musculus (house mouse) | 0.001 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 4 | |
Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0897 | |
Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 0.0042 | |
Regulatory-associated protein of mTOR | Homo sapiens (human) | 0.225 | |
Target of rapamycin complex subunit LST8 | Homo sapiens (human) | 0.225 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 1.9 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barsness, GW; Bjarnason, H; Howe, PW; Hunt, C; Mathew, V; McKusick, MA; Misra, S; Pflueger, A; Textor, SC; Thatipelli, MR | 1 |
Abul-Ezz, S; Arbiser, JL; Hiatt, KM; High, W; Horn, TD; Shah, SV; Swaminathan, S | 1 |
2 other study(ies) available for gadolinium dtpa and sirolimus
Article | Year |
---|---|
Preliminary study of the use of drug-eluting stents in atherosclerotic renal artery stenoses 4 mm in diameter or smaller.
Topics: Aged; Aged, 80 and over; Angiography; Drug-Eluting Stents; Female; Gadolinium DTPA; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Proportional Hazards Models; Recurrence; Renal Artery Obstruction; Retrospective Studies; Sirolimus; Stents; Treatment Outcome; Tubulin Modulators; Ultrasonography; Vascular Resistance | 2008 |
Rapid improvement of nephrogenic systemic fibrosis with rapamycin therapy: possible role of phospho-70-ribosomal-S6 kinase.
Topics: Contrast Media; Gadolinium DTPA; Humans; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus | 2010 |